Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production.

Inflammatory mechanisms contribute to atherogenesis. Monocyte chemoattractant protein (MCP)-1 and IL-6 are potent mediators of inflammation. Both contribute to early atherogenesis by luring monocytes and regulating cell functions in the vessel wall. MCP-1 and IL-6 production resulting from the interaction of invading monocytes with local vessel wall cells may accelerate atherosclerosis. We investigated the influence of the interaction of human vascular smooth muscle cells (SMCs) with human mononuclear cells (MNCs) or monocytes on IL-6 and MCP-1 production in a coculture model. Interaction synergistically enhanced IL-6 and MCP-1 production (up to 30- and 10-fold, respectively) compared with separately cultured cells. This enhancement was mediated by CD14-positive monocytes. It was dependent on the SMC-to-MNC/monocyte ratio, and as few as 0.2 monocytes/SMC induced the synergism. Synergistic IL-6 production was observed at the protein, mRNA, and functional level. It was mediated by soluble factors, and simultaneous inhibition of IL-1, TNF-alpha, and IL-6 completely blocked the synergism. IL-1, TNF-alpha, and IL-6 were present in the cultures. Blockade of the synergism by soluble glycoprotein 130Fc/soluble IL-6 receptor, as well as the induction of synergistic IL-6 production by costimulation of SMCs with IL-1, TNF-alpha, and hyper-IL-6, suggested the involvement of IL-6 trans-signaling. The contribution of IL-6 was consistent with enhanced STAT3 phosphorylation. The present data suggest that SMC/monocyte interactions may augment the proinflammatory status in the tissue, contributing to the acceleration of early atherogenesis.

[1]  K. Werdan,et al.  Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms , 2008, Innate immunity.

[2]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[3]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[4]  C. Uyttenhove,et al.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Lazzarin,et al.  Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. , 1998, Blood.

[6]  T. Kooistra,et al.  Cytokines and atherosclerosis: a comprehensive review of studies in mice , 2008, Cardiovascular research.

[7]  K. Werdan,et al.  Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. , 1998, Blood.

[8]  A. J. Valente,et al.  Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Arnal,et al.  Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. , 2001, Atherosclerosis.

[10]  P. Libby,et al.  Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. , 1989, Lymphokine research.

[11]  J. Gerdes,et al.  Human Vascular Smooth Muscle Cells Express Interleukin-1β–converting Enzyme (ICE), but Inhibit Processing of the Interleukin-1β Precursor by ICE , 1997, The Journal of experimental medicine.

[12]  S. Hegde,et al.  Novel immunosuppressive properties of interleukin‐6 in dendritic cells: inhibition of NF‐κB binding activity and CCR7 expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Amar,et al.  Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model. , 2008, Atherosclerosis.

[14]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[15]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[16]  A. Harken,et al.  Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. , 2002, American journal of physiology. Heart and circulatory physiology.

[17]  W. Newman,et al.  Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization. , 2003, The Journal of surgical research.

[18]  C. Trautwein,et al.  Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis , 2004, Circulation.

[19]  T. Hayek,et al.  Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL: A Possible Role for Interleukin-6 , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[21]  M. Neurath,et al.  Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. , 2001, European journal of biochemistry.

[22]  K. Werdan,et al.  Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1α , 2007, Journal of endotoxin research.

[23]  A. Ortiz,et al.  Angiotensin II and reactive oxygen species. , 2005, Antioxidants & redox signaling.

[24]  J. Scheller,et al.  Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.

[25]  T. Ogihara,et al.  Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. , 1990, Biochemistry international.

[26]  P. Libby,et al.  Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. , 1992, Experimental cell research.

[27]  P. Libby,et al.  Mast cells promote atherosclerosis by releasing proinflammatory cytokines , 2007, Nature Medicine.

[28]  Jianbin Wang,et al.  CD16+ monocytes produce IL‐6, CCL2, and matrix metalloproteinase‐9 upon interaction with CX3CL1‐expressing endothelial cells , 2006, Journal of leukocyte biology.

[29]  N. Jing,et al.  Role of JAK/STAT Pathway in IL-6-Induced Activation of Vascular Smooth Muscle Cells , 2004, American Journal of Nephrology.

[30]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[31]  A. Gearing,et al.  Induction of in vitro human lymphocyte migration by interleukin 3, interleukin 4, and interleukin 6. , 1990, Cytokine.

[32]  C. Fielding,et al.  Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. , 2007, Blood.

[33]  Masafumi Takahashi,et al.  MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species. , 2008, Cardiovascular research.

[34]  C. Tei,et al.  Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. , 2008, American journal of physiology. Heart and circulatory physiology.

[35]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[36]  P. Libby,et al.  Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. , 1989, Cellular immunology.

[37]  K. Werdan,et al.  Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. , 1998, Journal of molecular and cellular cardiology.

[38]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[39]  J. Banchereau,et al.  IL-6 switches the differentiation of monocytes from dendritic cells to macrophages , 2000, Nature Immunology.

[40]  H. Loppnow,et al.  Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells , 1998, Journal of Neuroimmunology.

[41]  U. Ikeda,et al.  Interaction between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression. , 2000, Atherosclerosis.

[42]  P. Heinrich,et al.  Differential shedding of the two subunits of the interleukin‐6 receptor , 1993, FEBS letters.

[43]  H. Nishimatsu,et al.  Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species. , 2008, American journal of physiology. Heart and circulatory physiology.

[44]  C. Weber,et al.  Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation , 2007, Thrombosis and Haemostasis.

[45]  S. Rose-John,et al.  Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. , 1999, Journal of immunology.

[46]  N. Maeda,et al.  Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.

[47]  P. Sakkinen,et al.  Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[48]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[49]  A. Parenti,et al.  Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[50]  P. Heinrich,et al.  Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. , 1998, Journal of immunology.

[51]  Stefan Rose-John,et al.  Dynamics of the gp130 cytokine complex: A model for assembly on the cellular membrane , 2005, Protein science : a publication of the Protein Society.